BSEShelter Pharma LtdMediumPositive
Announced Mon, 11 May · 11:04 IST

Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015- New Product Launch.

Business Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
prior close
₹32.39
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.5+0.5+1.9
Up moveDown movePending
AI summary

Shelter Pharma Ltd has announced the launch of a new healthcare product called FOLIMAN Folic Acid Tablets (Vitamin B-9 Supplement) on May 11, 2026. The product is part of the company's strategy to expand its healthcare and nutraceutical portfolio. The folic acid supplement will initially be launched in international markets, with plans to introduce it in the domestic market later. The company expects this launch to strengthen its market presence and support long-term growth in the healthcare segment.

Likely market impact

This is a routine product expansion announcement with no immediate financial impact. The international market launch signals potential export revenue opportunity, but no specific order values or revenue guidance were provided, limiting near-term stock impact.